Dechra Pharmaceuticals (DPH)

 

DPH Share PerformanceMore

52 week high2,149.0 12/09/17
52 week low1,225.0 09/12/16
52 week change 648.0 (48.29%)
4 week volume4,150,943 29/08/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Director Deals - Dechra Pharmaceuticals PLC (DPH)

Ian Page, Chief Executive Officer, sold post-exercise 54,910 shares in the company on the 19th September 2017 at a price of 2...

Director Deals - Dechra Pharmaceuticals PLC (DPH)

Tony Griffin, Executive Director, sold post-exercise 29,937 shares in the company on the 19th September 2017 at a price of 2...

Director/PDMR Shareholding

RNS Number: 3406R Dechra Pharmaceuticals PLC 20 September 2017 20 September 2017 Dechra Pharmaceuticals PLC (Dechra or the Company) Notification and public disclosure of transactions by persons discharging managerial responsibilities (PDMRs) Sale of shares: Dechra Pharmaceuticals PLC announces that on 19 September 2017, Ian Page and Tony Griffin s...

Director Deals - Dechra Pharmaceuticals PLC (DPH)

Tony Griffin, Executive Director, exercised 29,937 shares in the company on the 19th September 2017 at a price of 0.00p. Th...

Director Deals - Dechra Pharmaceuticals PLC (DPH)

Ian Page, Chief Executive Officer, exercised 115,334 shares in the company on the 19th September 2017 at a price of 0.00p. Th...

Director/PDMR Shareholding

RNS Number: 1712R Dechra Pharmaceuticals PLC 19 September 2017 19 September 2017 Dechra Pharmaceuticals PLC (Dechra or the Company) Notification and public disclosure of transactions by persons discharging managerial responsibilities (PDMRs) Dechra Pharmaceuticals PLC announces that on 19 September 2017, the following PDMRs exercised nil cost optio...

Annual Financial Report

RNS Number: 1476R Dechra Pharmaceuticals PLC 19 September 2017 Date: Tuesday, 19 September 2017 Dechra Pharmaceuticals PLC (the Company) Annual Financial Report The Company announced its Preliminary Results on 4 September 2017 in accordance with the financial reporting obligations of the Disclosure and Transparency Rules. Copies of the Annual Re...

BLOCK LISTING SIX MONTHLY RETURN

RNS Number: 9199Q Dechra Pharmaceuticals PLC 15 September 2017 BLOCK LISTING SIX MONTHLY RETURN Information provided on this form must be typed or printed electronically and provided to an ris . Date: 15 September 2017 Name of applicant: Dechra Pharmaceuticals PLC Name of scheme: Long-Term Incentive Scheme Period of return: From: 15 Ma...

Fundamental DataMore

P/E ratio70.844
EPS28.09
Dividend yield1.077 %

Equity Research (DPH)

edison investment research
Dechra Pharmaceuticals plc
10/09/2015
Dechra Pharmaceuticals delivered FY15 revenue growth of 10% CER to £203.5m and EPS growth of 16.9% from 36.3p to 39.9p, with strong sales performances in its Companion Animal Products (CAP) segment,...
edison investment research
Dechra Pharmaceuticals plc
08/07/2015
Dechra Pharmaceuticals’ medium-term outlook is underpinned by a sharpened portfolio focus, new product launches and geographic expansion. Solid performances on these fronts in FY15 have overcome the...
edison investment research
Dechra Pharmaceuticals plc
29/04/2015
Dechra Pharmaceuticals has delivered another solid quarter with revenue growth up 6.0% (14.3% CER), resulting in nine-month growth of 6.6% (12.3% CER). Although boosted by phasing of pre-Easter...

Latest discussion posts More

  • now cantor fitzgerald....

    .....telling clients to buy .....target #22 .new suit for xmas if they hit this target !!
    8-Sep-2017
    valeite
  • Re: numis says add

    That sounds positive Valeite. I think that this one may be a bit volatile as the valuation is so high that any bit of negative news could cause an exaggerated fall. From ...
    5-Sep-2017
    frog in a tree
  • numis says add

    price target #21.56
    5-Sep-2017
    valeite

Users' HoldingsMore

Users who hold Dechra Pharmaceuticals also hold..
NATIONAL GRID41%
DIAGEO34%
LLOYDS GRP.30%
GLAXOSMITHKLINE21%
PZ CUSSONS21%

Codes & Symbols

ISINGB0009633180
SymbolsDPH, LSE:DPH, DPH.L, DPH:LN, LON:DPH, XLON:DPH